The CEO/CFO sales are likely liquidity-driven following option exercises, not a bearish signal on fundamentals given the modest proportion of market cap. However, the cluster of three insiders selling within a week, including the CEO and CFO, adds mild caution. Monitor for any pipeline news (e.g., AXS-07, AXS-12, solriamfetol updates) that could explain the timing.
AXSM drugs
AXSM drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Jun 10 $246.34entry
- T+1 · 5mo ago +3.02%α +1.32% · $253.77
- T+5 · 5mo ago +2.26%α −1.17% · $251.91
- T+20 · 4mo ago +1.06%α −2.56% · $248.95
- T+60 · 2mo ago −15.42%α −22.00% · $208.35
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
CEO Herriot and CFO Pizzie exercised stock options and immediately sold the resulting shares in open-market transactions on June 9, 2026, generating ~$19.9M in total proceeds. Director Coleman also sold $1.24M on June 2. The cluster is entirely sell-side with $21.1M in open-market sales, representing ~0.17% of AXSM's $12.1B market cap, a modest but notable amount. The CEO/CFO sales follow option exercises and are likely tax/planning driven, but the timing ahead of potential catalysts (e.g., pipeline updates) warrants monitoring.
Key Financial Metrics
Key Facts
- CEO Herriot sold 49,670 shares at ~$241.01 for ~$12.0M on June 9, 2026
- CFO Pizzie sold 33,000 shares at ~$240.09 for ~$7.9M on June 9, 2026
- Both CEO and CFO exercised options at $0-$4.95 cost basis before selling, no net cash outlay for the shares
- Director Coleman sold 5,500 shares at $223.39 for ~$1.24M on June 2, 2026
- Total open-market sales: ~$21.1M, or ~0.17% of AXSM's $12.1B market cap
- Two directors received non-cash grants of 1,721 shares each on June 5, 2026, no economic signal
- AXSM has 93% analyst bullish consensus (25 Buy/Strong Buy, 2 Hold)
Financial Impact
Total insider sales of ~$21.1M represent ~0.17% of market cap, modest but notable for a biotech with significant pipeline value
Risk Factors
- CEO/CFO selling after option exercises could signal reduced conviction ahead of pipeline milestones
- Director Coleman's sale at a lower price ($223.39) vs. CEO/CFO ($240-241) suggests no coordinated bearish view
- Biotech sector volatility could amplify any negative read-through from insider sales
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-AXSM-1781039864729 |
Track record
26 reports on AXSM
6 of 8 bullish or bearish reports moved the stock their way by T+5. Best: +14.74% at T+60 after the Apr 30, 2026 report. 7 of 8 went positive at some point.
Filters
- Nov 2, 202614d ago 8-K Bullish 6/10 No price data
- Nov 2, 202614d ago Press Release Bullish 6/10 Entry $136.01 to $133.96 Now $137.01 +0.74% ▼ −1.51% −1.59% vs SPY
- Oct 20, 202627d ago Institutional Cluster Bearish 4/10 Entry $156.31 to $142.20 Now $137.01 +12.35% ▲ +9.03% +8.58% vs SPY
- Aug 11, 202613w ago Institutional Cluster Mixed 5/10 Entry $214.66 to $218.20 Now $137.01 −36.17% ▲ +1.65% +2.09% vs SPY
- Aug 10, 202614w ago 8-K Neutral 6/10 No price data
- Aug 10, 202614w ago Press Release Mixed 6/10 Entry $220.89 to $216.27 Now $137.01 −37.97% ▼ −2.09% −2.04% vs SPY
- Jul 15, 202617w ago Press Release Bullish 6/10 Entry $237.53 to $239.62 Now $137.01 −42.32% ▲ +0.88% +1.86% vs SPY
- Jul 9, 202618w ago Court Ruling Bullish 5/10 Entry $248.95 to $237.04 Now $137.01 −44.96% ▼ −4.78% −4.65% vs SPY
- Jul 7, 202618w ago Press Release Neutral 4/10 Entry $249.76 to $235.26 Now $137.01 −45.14% ▼ −5.81% −6.36% vs SPY
- Jul 1, 202619w ago 144 Neutral 4/10 Entry $244.31 to $248.95 Now $137.01 −43.92% ▲ +1.90% +0.97% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers